Lack of Myocardial Perfusion Immediately After Successful Thrombolysis: A Predictor of Poor Recovery of Left Ventricular Function in Anterior Myocardial Infarction

BackgroundWe investigated myocardial perfusion dynamics after thrombolysis and its clinical implications. Methods and ResultsWe studied 39 patients with acute anterior myocardial infarction (AMI). Myocardial contrast echocardiography (MCE) was performed before and immediately after successful reflow with intracoronary injection of sonicated loxaglate. The average segmental score by twodimensional echocardiography (graded 0, normal, to 3, akinetic/dyskinetic) and global ejection fraction (left ventricular ejection fraction, LVEF%) by left ventriculography were measured at 1 day and at 4 weeks after reflow. Hypokinesis in the infarct region was assessed by the centerline method and expressed in terms of standard deviations (regional wall motion [RWM:SD/chord) of normal. Immediately after reflow, 30 of 39 patients (group A) showed significant contrast enhancement within the risk area. The other nine patients (23%, group B), however, showed the residual contrast defect in the risk area (myocardial no reflow). There were no significant differences in the elapsed time, angiographic collateral grade, and degree of residual stenosis between group A and group B. Before reflow, both groups exhibited similar levels of global and regional left ventricular function. Improvement in global (LVEF, average segmental score) and regional left ventricular function was greater in group A than in group B (average segmental score, 0.44±0.41 versus 0.97±0.36, p < 0.01; LVEF, 56.4± 13.4 versus 42.7±8.9, p < 0.0S; RWM, −1.87±0.85 versus −3.18±0.52, p < O.O05). ConclusionsMCE demonstrates that angiographically successful reflow cannot be used as an indicator of successful myocardial reperfusion in AMI patients. The residual contrast defect in the risk area demonstrated immediately after reflow is a predictor of poor functional recovery of the postischemic myocardium.

[1]  S S Segal,et al.  The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography. , 1989, Circulation research.

[2]  R. Kloner,et al.  “Reperfusion Injury” by Oxygen‐Derived Free Radicals?: Effect of Superoxide Dismutase Plus Catalase, Given at the Time of Reperfusion, on Myocardial Infarct Size, Contractile Function, Coronary Microvasculature, and Regional Myocardial Blood Flow , 1989, Circulation research.

[3]  R. Jennings,et al.  Myocardial neutrophil accumulation during reperfusion after reversible or irreversible ischemic injury. , 1988, The American journal of physiology.

[4]  J. Bristow,et al.  No reflow and extent of infarction during maximal vasodilation in the porcine heart. , 1988, Circulation.

[5]  R. Kerber,et al.  Myocardial risk area and peak gray level measurement by contrast echocardiography: effect of microbubble size and concentration, injection rate, and coronary vasodilation. , 1988, American heart journal.

[6]  R. Virmani,et al.  Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. , 1987, Circulation.

[7]  A. Weyman,et al.  The importance of defining left ventricular area at risk in vivo during acute myocardial infarction: an experimental evaluation with myocardial contrast two-dimensional echocardiography. , 1987, Circulation.

[8]  M. Pfeffer,et al.  Ventricular enlargement and reduced survival after myocardial infarction. , 1987, Circulation.

[9]  R. Kloner,et al.  Analysis of reported randomized trials of streptokinase therapy for acute myocardial infarction in the 1980s. , 1987, The American journal of cardiology.

[10]  H W Woo,et al.  Advantages and applications of the centerline method for characterizing regional ventricular function. , 1986, Circulation.

[11]  R. Kloner,et al.  Salvage of ischaemic myocardium by reperfusion: importance of collateral blood flow and myocardial oxygen demand during occlusion. , 1986, Cardiovascular research.

[12]  A. Weyman,et al.  Contrast echocardiography in acute myocardial ischemia. II. The effect of site of injection of contrast agent on the estimation of area at risk for necrosis after coronary occlusion. , 1985, Journal of the American College of Cardiology.

[13]  E. Braunwald.  The aggressive treatment of acute myocardial infarction. , 1985, Circulation.

[14]  J. Schofer,et al.  Scintigraphic evidence of the "no reflow" phenomenon in human beings after coronary thrombolysis. , 1985, Journal of the American College of Cardiology.

[15]  A. Parisi,et al.  Hydrogen peroxide contrast echocardiography: quantification in vivo of myocardial risk area during coronary occlusion and of the necrotic area remaining after myocardial reperfusion. , 1984, Circulation.

[16]  M. Fishbein,et al.  Verification of myocardial contrast two-dimensional echocardiographic assessment of perfusion defects in ischemic myocardium. , 1984, Journal of the American College of Cardiology.

[17]  M. Schork,et al.  Reduction of the Extent of Ischemic Myocardial Injury by Neutrophil Depletion in the Dog , 1983, Circulation.

[18]  E. Braunwald,et al.  Ultrastructural Evidence of Microvascular Damage and Myocardial Cell Injury After Coronary Artery Occlusion: Which Comes First? , 1980, Circulation.

[19]  R. Kloner,et al.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog. , 1974, The Journal of clinical investigation.